Research ArticleOriginal Article
Open Access

Recognition of oxidized albumin and thyroid antigens by psoriasis autoantibodies

A possible role of reactive-oxygen-species induced epitopes in chronic plaque psoriasis

Hani A. Al-Shobaili, Ahmed A. Ahmed and Zafar Rasheed
Saudi Medical Journal December 2015, 36 (12) 1408-1419; DOI: https://doi.org/10.15537/smj.2015.12.12612

References

  1. ↵
    1. Raychaudhuri SK,
    2. Maverakis E,
    3. Raychaudhuri SP
    (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490–495.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Hueber AJ,
    2. Manger B
    (2013) New aspects on the pathogenesis of psoriatic arthritis. Z Rheumatol 72:758–763.
    OpenUrl
  3. ↵
    1. Levine D,
    2. Gottlieb A
    (2009) Evaluation and management of psoriasis: an internist’s guide. Med Clin North Am 93:1291–1303.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Kadam DP,
    2. Suryakar AN,
    3. Ankush RD,
    4. Kadam CY,
    5. Deshpande KH
    (2010) Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem 25:388–392.
    OpenUrlPubMed
    1. Zhou Q,
    2. Mrowietz U,
    3. Rostami-Yazdi M
    (2009) Oxidative stress in the pathogenesis of psoriasis. Free Radic Biol Med 47:891–905.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Basavaraj KH,
    2. Vasu Devaraju P,
    3. Rao KS
    (2013) Studies on serum 8-hydroxy guanosine (8-OHdG) as reliable biomarker for psoriasis. J Eur Acad Dermatol Venereol 27:655–657.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Rashmi R,
    2. Rao KS,
    3. Basavaraj KH
    (2009) A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol 34:658–663.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Hsu LN,
    2. Armstrong AW
    (2012) Psoriasis and autoimmune disorders: a review of the literature. J Am Acad Dermatol 67:1076–1079.
    OpenUrlCrossRefPubMed
    1. Singh S,
    2. Singh U,
    3. Singh S
    (2010) Prevalence of autoantibodies in patients of psoriasis. J Clin Lab Anal 24:44–48.
    OpenUrlPubMed
  10. ↵
    1. Wu JJ,
    2. Nguyen TU,
    3. Poon KY,
    4. Herrinton LJ
    (2012) The association of psoriasis with autoimmune diseases. J Am Acad Dermatol 67:924–930.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Lora V,
    2. Bonaguri C,
    3. Gisondi P,
    4. Sandei F,
    5. Battistelli L,
    6. Russo A,
    7. Melegari A,
    8. Trenti T,
    9. Lippi G,
    10. Girolomoni G
    (2013) Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunol Res 56:382–389.
    OpenUrlCrossRefPubMed
    1. Jullien D
    (2012) Anti-drug antibodies, auto-antibodies and biotherapy in psoriasis. Ann Dermatol Venereol 139:S58–S67.
    OpenUrlCrossRefPubMed
    1. Azarsiz E,
    2. Ertam I,
    3. Karaca N,
    4. Aksu G,
    5. Alper S,
    6. Kutukculer N
    (2012) IgG-anti-IgA antibodies: an autoimmune finding in patients with psoriasis vulgaris. Minerva Med 103:183–187.
    OpenUrlPubMed
    1. Ohata C,
    2. Mori Y,
    3. Tokita T,
    4. Koga H,
    5. Ohyama B,
    6. Sogame R,
    7. Hamada T,
    8. Ishii N,
    9. Furumura M,
    10. Hashimoto T
    (2012) Pemphigoid with autoantibodies to all laminin 332 subunits and BP230 developing vesicles within psoriatic plaques. Eur J Dermatol 22:812–813.
    OpenUrl
  15. ↵
    1. Popescu C,
    2. Zofota S,
    3. Bojinca V,
    4. Ionescu R
    (2013) Anti-cyclic citrullinated peptide antibodies in psoriatic arthritis cross-sectional study and literature review. Med Life 6:376–382.
    OpenUrl
  16. ↵
    1. Safer JD
    (2011) Thyroid hormone action on skin. Dermatoendocrinol 3:211–215.
    OpenUrlPubMed
    1. Safer JD,
    2. Persons K,
    3. Holick MF
    (2009) A thyroid hormone deiodinase inhibitor can decrease cutaneous cell proliferation in vitro. Thyroid 19:181–185.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Artantas S,
    2. Gul U,
    3. Kilic A,
    4. Guler S
    (2009) Skin findings in thyroid diseases. Eur J Intern Med 20:158–161.
    OpenUrlPubMed
  19. ↵
    1. Robati RM,
    2. Toossi P,
    3. Rahmati-Roodsari M,
    4. Khalilazar S,
    5. Abolhasani E,
    6. Namazi N,
    7. Younespour S
    (2013) Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment. Scientific World Journal 2013:921819.
    OpenUrl
  20. ↵
    1. Gul U,
    2. Gonul M,
    3. Kaya I,
    4. Aslan E
    (2009) Autoimmune thyroid disorders in patients with psoriasis. Eur J Dermatol 19:221–223.
    OpenUrlPubMed
  21. ↵
    1. Zoabi A,
    2. Ziv M,
    3. Rozenman D,
    4. Lovoshitski R
    (2012) Prevalence of thyroid abnormalities among psoriatic patients. Harefuah 151:566–569.
    OpenUrl
  22. ↵
    1. Sugawara M
    (2014) Reactive oxygen species and thyroid diseases. Systems Biol Free Radic Antioxid, 3521–3538.
    1. Elnakish MT,
    2. Schultz EJ,
    3. Gearinger RL,
    4. Saad NS,
    5. Rastogi N,
    6. Ahmed AA,
    7. et al.
    (2015) Differential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles. Free Radic Biol Med 83:252–261.
    OpenUrl
  24. ↵
    1. Campos C,
    2. Casado A
    (2015) Oxidative stress, thyroid dysfunction & amp; Down syndrome. Indian J Med Res 142:113–119.
    OpenUrlPubMed
  25. ↵
    1. Villanueva I,
    2. Alva-Sanchez C,
    3. Pacheco-Rosado J
    (2013) The role of thyroid hormones as inductors of oxidative stress and neurodegeneration. Oxid Med Cell Longev 2013:218145.
    OpenUrl
  26. ↵
    1. Johnson MA,
    2. Armstrong AW
    (2013) Clinical and histologic diagnostic guidelines for psoriasis: a critical review. Clin Rev Allergy Immunol 44:166–172.
    OpenUrl
  27. ↵
    1. Khan S,
    2. Moinuddin Alam R,
    3. Ali A
    (2010) Oxidatively Damaged DNA: A Possible Antigenic Stimulus for Cancer Autoantibodies. Indian J Clin Biochem 25:244–249.
    OpenUrlPubMed
  28. ↵
    1. Pena Luengas SL,
    2. Marin GH,
    3. Aviles K,
    4. Cruz Acuna R,
    5. Roque G,
    6. Rodriguez Nieto F,
    7. et al.
    (2014) Enhanced singlet oxygen production by photodynamic therapy and a novel method for its intracellular measurement. Cancer Biother Radiopharm 29:435–443.
    OpenUrl
  29. ↵
    1. Rasheed Z,
    2. Ahmad R,
    3. Ali R
    (2009) Structure and immunological function of oxidised albumin in lung cancer: its potential role as a biomarker of elevated oxidative stress. Br J Biomed Sci 66:67–73.
    OpenUrlPubMed
  30. ↵
    1. Al-Shobaili HA,
    2. Rasheed Z
    (2012) Immunological studies of oxidized superoxide dismutase in patients with systemic lupus erythematosus. Correlation with disease induction and progression. Saudi Med J 33:1177–1184.
    OpenUrlPubMed
  31. ↵
    1. Al-Shobaili HA,
    2. Al Robaee AA,
    3. Alzolibani AA,
    4. Rasheed Z
    (2012) Antibodies against 4-hydroxy-2-nonenal modified epitopes recognized chromatin and its oxidized forms: role of chromatin, oxidized forms of chromatin and 4-hydroxy-2-nonenal modified epitopes in the etiopathogenesis of SLE. Dis Markers 33:19–34.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Rasheed Z,
    2. Alzolibani AA,
    3. Al-Shobaili HA,
    4. Saif GB,
    5. Al Robaee AA
    (2014) Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis. Immunol Lett 160:50–57.
    OpenUrl
  33. ↵
    1. Alghasham A,
    2. Al Salloom AA,
    3. Alghamadi AS,
    4. Rasheed Z
    (2015) Impact of anti-peroxynitrite-damaged-thymidine-monophosphate antibodies on disease activity in patients with systemic lupus erythematosus. Nucleosides Nucleotides Nucleic Acids 34:56–68.
    OpenUrl
  34. ↵
    1. Al-Shobaili HA,
    2. Rasheed Z
    (2014) Mitochondrial DNA acquires immunogenicity on exposure to nitrosative stress in patients with vitiligo. Hum Immunol 75:1053–1061.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Alzolibani AA,
    2. Al Robaee AA,
    3. Al-Shobaili HA,
    4. Rasheed Z
    (2013) 4-hydroxy-2-nonenal modified histone-H2A: A possible antigenic stimulus for systemic lupus erythematosus autoantibodies. Cell Immunol 284:154–162.
    OpenUrl
  36. ↵
    1. Frohnert BI,
    2. Bernlohr DA
    (2013) Protein carbonylation, mitochondrial dysfunction, and insulin resistance. Adv Nutr 4:157–163.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Perera GK,
    2. Di Meglio P,
    3. Nestle FO
    (2012) Psoriasis. Annu Rev Pathol 7:385–422.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Raychaudhuri SK,
    2. Maverakis E,
    3. Raychaudhuri SP
    (2014) Diagnosis and classification of psoriasis. Autoimmun Rev 13:490–495.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Al-Shobaili HA,
    2. Alzolibani AA,
    3. Al Robaee AA,
    4. Meki AR,
    5. Rasheed Z
    (2013) Biochemical markers of oxidative and nitrosative stress in acne vulgaris: correlation with disease activity. J Clin Lab Anal 27:45–52.
    OpenUrl
  40. ↵
    1. Gnanaraj P,
    2. Dayalan H,
    3. Elango T,
    4. Malligarjunan H,
    5. Raghavan V,
    6. Rao R
    (2015) Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis. Int J Dermatol 54:302–306.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section